We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXC icon
226
Exelon
EXC
$48.1B
$12.5M 0.09%
324,772
+220,620
+212% +$9.2M
ARVN icon
227
Arvinas
ARVN
$530M
$12.4M 0.09%
494,947
-39,055
-7% -$1.23M
PTCT icon
228
PTC Therapeutics
PTCT
$6.18B
$12.4M 0.09%
277,652
+75,000
+37% +$3.43M
IEX icon
229
IDEX
IEX
$17B
$12.4M 0.09%
58,124
+42,841
+280% +$9.73M
EG icon
230
Everest Group
EG
$15.6B
$12.3M 0.09%
37,285
-22,633
-38% -$8.13M
RVMD icon
231
Revolution Medicines
RVMD
$38.5B
$12.1M 0.08%
606,332
-126,173
-17% -$3.11M
JEF icon
232
Jefferies Financial Group
JEF
$12.7B
$11.9M 0.08%
407,713
-119,172
-23% -$4.31M
OI icon
233
O-I Glass
OI
$1.18B
$11.7M 0.08%
561,385
-383,217
-41% -$8.04M
ITW icon
234
Illinois Tool Works
ITW
$84.1B
$11.7M 0.08%
52,096
-81,803
-61% -$19.1M
MCO icon
235
Moody's
MCO
$83.7B
$11.6M 0.08%
41,085
+1,569
+4% +$474K
WMT icon
236
Walmart Inc
WMT
$909B
$11.6M 0.08%
255,798
+22,464
+10% +$1.07M
AMT icon
237
American Tower
AMT
$83.5B
$11.5M 0.08%
61,360
-3,000
-5% -$629K
MU icon
238
Micron Technology
MU
$835B
$11.5M 0.08%
206,382
+37,145
+22% +$2.18M
BKNG icon
239
Booking.com
BKNG
$156B
$11.3M 0.08%
115,700
+33,675
+41% +$3.28M
GH icon
240
Guardant Health
GH
$19.1B
$11.2M 0.08%
521,182
+61,538
+13% +$1.76M
KRTX
241
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$11.2M 0.08%
67,201
-15,000
-18% -$2.87M
MRSN
242
DELISTED
Mersana Therapeutics
MRSN
$11.2M 0.08%
118,514
+10,800
+10% +$1.52M
RMD icon
243
ResMed
RMD
$31.1B
$11.2M 0.08%
55,528
+3,053
+6% +$662K
TMUS icon
244
T-Mobile US
TMUS
$195B
$11.1M 0.08%
82,895
-23,661
-22% -$3.43M
CCK icon
245
Crown Holdings
CCK
$13B
$10.9M 0.08%
143,823
-1,415
-1% -$120K
COP icon
246
ConocoPhillips
COP
$144B
$10.9M 0.08%
119,845
+13,469
+13% +$1.47M
ZTS icon
247
Zoetis
ZTS
$32.7B
$10.9M 0.08%
71,302
-21,624
-23% -$3.54M
LKQ icon
248
LKQ Corp
LKQ
$6.72B
$10.8M 0.08%
207,567
-3,282
-2% -$185K
REPL icon
249
Replimune Group
REPL
$455M
$10.8M 0.07%
662,922
DE icon
250
Deere & Co
DE
$165B
$10.6M 0.07%
27,935
+2,602
+10% +$1.08M

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.